首页> 外文期刊>Journal of immunology research. >Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis
【24h】

Meta-Analysis of Expression Profiling Data Indicates Need for Combinatorial Biomarkers in Pediatric Ulcerative Colitis

机译:表达分析数据的Meta分析表明需要在小儿溃疡性结肠炎中组合生物标志物

获取原文
           

摘要

Background. Unbiased studies using different genome-wide methods have identified a great number of candidate biomarkers for diagnosis and treatment response in pediatric ulcerative colitis (UC). However, clinical translation has been proven difficult. Here, we hypothesized that one reason could be differences between inflammatory responses in an inflamed gut and in peripheral blood cells. Methods. We performed meta-analysis of gene expression microarray data from intestinal biopsies and whole blood cells (WBC) from pediatric patients with UC and healthy controls in order to identify overlapping pathways, predicted upstream regulators, and potential biomarkers. Results. Analyses of profiling datasets from colonic biopsies showed good agreement between different studies regarding pathways and predicted upstream regulators. The most activated predicted upstream regulators included TNF, which is known to have a key pathogenic and therapeutic role in pediatric UC. Despite this, the expression levels of TNF were increased in neither colonic biopsies nor WBC. A potential explanation was increased expression of TNFR2, one of the membrane-bound receptors of TNF in the inflamed colon. Further analyses showed a similar pattern of complex relations between the expression levels of the regulators and their receptors. We also found limited overlap between pathways and predicted upstream regulators in colonic biopsies and WBC. An extended search including all differentially expressed genes that overlapped between colonic biopsies and WBC only resulted in identification of three potential biomarkers involved in the regulation of intestinal inflammation. However, two had been previously proposed in adult inflammatory bowel diseases (IBD), namely, MMP9 and PROK2. Conclusions. Our findings indicate that biomarker identification in pediatric UC is complicated by the involvement of multiple pathways, each of which includes many different types of genes in the blood or inflamed intestine. Therefore, further studies for identification of combinatorial biomarkers are warranted. Our study may provide candidate biomarkers for such studies.
机译:背景。使用不同基因组的方法的无偏见研究已经确定了大量候选生物标志物用于小儿溃疡性结肠炎(UC)中的诊断和治疗反应。但是,临床翻译已被证明很难。在这里,我们假设一种原因可能是发炎的肠道和外周血细胞中炎症反应之间的差异。方法。我们对来自肠道活组织检查和全血细胞(WBC)的基因表达微阵列数据进行了Meta分析,来自儿科患者和健康对照,以鉴定重叠的途径,预测上游调节剂和潜在的生物标志物。结果。结肠活检的分析数据集分析表现出对途径和预测上游调节因子的不同研究之间的良好一致性。最活化的预测上游调节剂包括TNF,已知在儿科UC中具有关键的致病和治疗作用。尽管如此,TNF的表达水平既不增加结肠生物检查,也不是WBC。潜在的解释是在发炎结肠中TNF的膜结合受体之一的表达增加了TNFR2的表达。进一步分析显示了调节剂和受体的表达水平之间的类似模式的复杂关系。我们还在途径和预测结肠生物检查和WBC中发现了有限的重叠。扩展搜索包括所有差异表达的基因,这些基因在结肠生物检查和WBC之间仅导致鉴定参与肠炎症的三个潜在的生物标志物。然而,先前已经提出了成人炎症肠疾病(IBD),即MMP9和PROK2。结论。我们的发现表明,儿科UC中的生物标志物鉴定因多种途径的累及而复杂化,每个途径包括血液中的许多不同类型的基因或发炎的肠道。因此,有必要进一步研究用于鉴定组合生物标志物。我们的研究可以为这些研究提供候选生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号